Abstract:Ovarian cancer is a poorly understood disease with 75% death rate when identified after metastasis. Drug resistance and tumor recurrence are likely due to cancer stem-like cells (CSCs) that evade chemotherapy and induce relapse with phenotypes that are distinct from bulk tumor cells. It remains unclear how CSCs facilitate relapse and what role the tumor microenvironment (TME) plays in this process. Our preliminary data show that a secreted cytokine, tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and its receptor Fn14 are overexpressed in ovarian tumors and increase after chemotherapy. TWEAK is a strong inducer of stem cell features and enhances survival of CSCs during chemotherapy exposure. The source of TWEAK has not been clarified, although clinical data from human ovarian tumors show that TWEAK mRNA was primarily observed in a subset of infiltrating immune cells known as tumor associated macrophages (TAMs). When we evaluated TWEAK expression in cells found in the ovarian TME, including PBMC and THP-1-derived macrophages, IMR-90 activated fibroblasts, and ovarian cancer cell lines, we found that PBMC macrophages were the primary source of TWEAK production. Since cytotoxic chemotherapy can enrich for different TAM populations, we propose that TWEAK producing TAMs support CSC survival and expansion and contribute to the high rate of relapse in ovarian cancer patients. We further found that treatment with a small molecule inhibitor of TAM polarization leads to decreased TWEAK production, fewer CSCs, and prolonged remission in mouse models of ovarian cancer relapse as compared to vehicle. Currently we are testing whether knockout of Fn14 in ovarian cancer cells co-cultured with TAMs reduces stem cell features dependent on TWEAK-Fn14 signaling. Identification of immune populations responsible for TWEAK production could lead to new therapeutic strategies for patients with high rates of relapse. Citation Format: Luisjesus S. Cruz, Denay Stevenson, Mikella Robinson, Steffy Mathew, Isabella Amador, Gregory Jordan, Carrie D. House. Role of macrophages in the development of ovarian cancer stem-like cells during chemotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 163.

Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer

Tumor-Associated Macrophages (tams): A Critical Activator in Ovarian Cancer Metastasis

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy

The Role of Tumor-Associated Macrophages in Breast Cancer Progression

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction

Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy

Ott_a_216355 8687..8699

Tumor‐associated Macrophages in Immunotherapy

Tumor-associated Macrophages Promote Invasion Via Toll-like Receptors Signaling in Patients with Ovarian Cancer

Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer

Tumor-associated Macrophages Drive Spheroid Formation During Early Transcoelomic Metastasis of Ovarian Cancer.

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma

Tumor-Associated Myeloid Cells in Cancer Progression

Therapeutic Potential of Tumor Associated Macrophages

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment

Abstract 163: Role of macrophages in the development of ovarian cancer stem-like cells during chemotherapy

Tumor associated macrophages in breast cancer progression: implications and clinical relevance

Ovarian cancer derived extracellular vesicles promote the cancer progression and angiogenesis by mediating M2 macrophages polarization